Bank Of New York Mellon Corp Akouos, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $197,998 - $418,532	-80,487 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$4.16 - $9.08 $7,479 - $16,325	-1,798 Reduced 2.19%	80,487 $382,000
Q4 2021 Feb 11, 2022	SELL	$7.65 - $11.38 $14,718 - $21,895	-1,924 Reduced 2.28%	82,285 $700,000
Q3 2021 Nov 12, 2021	BUY	$9.93 - $13.59 $88,416 - $121,005	8,904 Added 11.82%	84,209 $978,000
Q2 2021 Aug 11, 2021	BUY	$11.87 - $15.96 $74,507 - $100,180	6,277 Added 9.09%	75,305 $945,000
Q1 2021 May 13, 2021	BUY	$13.87 - $21.04 $179,075 - $271,647	12,911 Added 23.01%	69,028 $957,000
Q4 2020 Feb 09, 2021	BUY	$17.03 - $22.45 $338,794 - $446,620	19,894 Added 54.92%	56,117 $1.11 Million
Q3 2020 Nov 12, 2020	BUY	$19.3 - $26.92 $699,103 - $975,123	36,223 New	36,223 $828,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.